ADAI News & Events
November 30, 2022
ADAI CERP Report to Legislature Details Public Health Risks for High-THC Cannabis

In early fall, ADAI Acting Associate Professor Beatriz Carlini, PhD, MPH and her team at the Cannabis Education & Research Program (CERP) published and delivered a report to the Washington State legislature that addresses the public health challenges of cannabis products with high concentrations of THC, the psychoactive ingredient in cannabis that causes a “high.”…
November 29, 2022
ADAI Lunch & Learn: Screening & Treating Cannabis Use Disorder in Primary Care (Dec. 6, 12pm PT)

Join ADAI and presenter Tessa Matson, MPH (PhD Candidate), UW School of Public Health, for our December Lunch & Learn session: Evaluation of Screening, Assessment, Diagnosis and Treatment for Cannabis Use Disorder in Primary CareDecember 6, 202212-1pm PTRegister here Nearly 44 million people use cannabis in the past year, and of those, 21% use cannabis daily….
November 23, 2022
New from ADAI: Provider Perspectives on Medication Treatment for OUD in Adolescents

Despite recent surges in adolescent opioid use disorder (OUD), teens are less likely to enter treatment compared to adults, and are rarely in treatment settings that offer evidence-based medication treatment (methadone, buprenorphine, and naltrexone). Buprenorphine is the only medication approved for people under 18 (aged 16 and older) and methadone requires written parental consent for…
November 10, 2022
Looking for ADAI Events?

Looking for upcoming events hosted by the UW Addictions, Drug & Alcohol Institute? You can find our events a few different ways: Subscribe to the ADAI News & Events blog (this!) and get notices about events hosted by ADAI and its various centers and teams (CEDEER, CAAHS and the Northwest ATTC, CERP, CTN, and more!),…
November 8, 2022
New ADAI Report: Overdose Deaths Involving Prescription Opioids in WA, 2010-2021

This new report by Caleb Banta-Green, PhD, MPH, MSW and Jason Williams, PhD of the ADAI Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) examines key indicators related to pharmaceutical opioids including sales data and overdose death rates. Key Points Prescription opioid overdose deaths declined from their peak in 2006, but are higher than…
November 7, 2022
New Research from ADAI: Opioid Safety Intervention for Community Pharmacists

ADAI Research Associate Professor Anthony Floyd, PhD has a new paper out describing an assessment of community pharmacists’ readiness to implement an educational program that aims to boost their knowledge and confidence when it comes to providing opioid safety and harm reduction services to patients and customers. What is the context for this study? Community…
November 4, 2022
How Can We Solve King County’s Fentanyl Problem? Seattle Met Article Feat. Caleb Banta-Green

Seattle Met magazine has two new stories about fentanyl in King County, both by Angela Cabotaje. The first, “How Can We Solve King County’s Fentanyl Problem?,” features ADAI Acting Professor Caleb Banta-Green, PhD, MPH, MSW, describing the impact pharmaceutical companies had on the opioid overdose crisis, and the innovative program Bupe Pathways, which is helping…
ADAI Hiring for 3 Open Positions!

ADAI is currently recruiting for 3 open positions! Here’s the information: Administrative Assistant (60% FTE) Update: this position has closed! This position supports the administrative staff, research scientists, faculty, and the information team at ADAI with a range of tasks, including general administrative assignments, scheduling meetings, contributing to written materials and web page content, helping…
November 1, 2022
ADAI Lunch & Learn: Improving Interactions Between Law Enforcement and People Who Use Substances (Nov 16, 12pm)

Please join us on November 16 (12-1pm PT) for our next ADAI Lunch & Learn session, featuring ADAI Assistant Professor Mandy Owens, PhD. In this talk, Dr. Owens will introduce and provide updates on two ongoing projects with law enforcement: a) developing training content on substance use disorders for the statewide basic law enforcement academy,…
ADAI’s Bia Carlini, PhD Interviewed on Q13 About High-THC Cannabis Products

Acting Associate Professor Beatriz Carlini, PhD, director of ADAI’s Cannabis Education & Research Program (CERP), was recently interviewed for Q13 FOX about the health risks of high-THC cannabis products. Dr. Carlini talks in the video about how cannabis legalization brought new jobs and less criminalization of individuals, both good things, but that the market has…
Previous page Next page